Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Lung Chemoemobolization

NCT05672108 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT05672108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05672108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Lung Chemoemobolization
Lead sponsor
City of Hope Medical Center
Phase
Phase 2
Overall status
Recruiting
Start date
May 12, 2023
Completion date
October 28, 2027
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer, endobronchial metastases, lung metastases from any primary, lung non-small cell carcinoma, mediastinal neoplasm, pleural neoplasm, sarcoma